Ben Chang
Algemeen Directeur bij PhorMed, Inc.
Actieve functies van Ben Chang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
PhorMed, Inc.
 PhorMed, Inc. Medical SpecialtiesHealth Technology PhorMed, Inc. operates as a clinical stage biopharmaceutical company. The company was founded by McCoy Moretz and is headquartered in Beverly Hills, CA. | Algemeen Directeur | - | - |
| Voorzitter | - | - | |
| Financieel Directeur/CFO | - | - |
Loopbaan van Ben Chang
Eerdere bekende functies van Ben Chang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| RICH PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 18-07-2013 | 24-06-2019 |
| Algemeen Directeur | 18-07-2013 | 24-06-2019 | |
| Voorzitter | 18-07-2013 | 24-06-2019 | |
| Financieel Directeur/CFO | 18-07-2013 | 24-06-2019 | |
| Investor Relations Contact | 18-07-2013 | - | |
| Public Communications Contact | 18-07-2013 | - | |
| President | 18-07-2013 | 24-06-2019 | |
| Bedrijfssecretaris | 18-07-2013 | 24-06-2019 | |
| Treasurer | 18-07-2013 | 24-06-2019 | |
Biosuccess Biotech Co. Ltd. ,
 Biosuccess Biotech Co. Ltd. , BiotechnologyHealth Technology Biosuccess Biotech Co. Ltd. develops PD-616 for the treatment of AML and HIV/AIDS. The private company is based in Los Angeles, CA. | Operationeel Directeur | 01-10-2006 | 01-01-2013 |
| Financieel Directeur/CFO | 01-10-2006 | 01-01-2013 | |
| President | 01-10-2006 | 01-01-2013 |
Opleiding van Ben Chang
| East Carolina University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Director of Finance/CFO | 3 |
| Chief Executive Officer | 2 |
| Chairman | 2 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Rich Pharmaceuticals, Inc.
 Rich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rich Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages on developing innovative therapies in oncology. It develops RP-323 for the treatment of Hodgkin’s lymphoma, Acute Myelogenous Leukemia, and to cause elevation of white blood cells in patients depleted of these elements due to various conditions. The company was founded on August 9, 2010 and is headquartered in Beverly Hills, CA. | Health Technology |
Biosuccess Biotech Co. Ltd. ,
Biosuccess Biotech Co. Ltd. , BiotechnologyHealth Technology Biosuccess Biotech Co. Ltd. develops PD-616 for the treatment of AML and HIV/AIDS. The private company is based in Los Angeles, CA. | Health Technology |
PhorMed, Inc.
PhorMed, Inc. Medical SpecialtiesHealth Technology PhorMed, Inc. operates as a clinical stage biopharmaceutical company. The company was founded by McCoy Moretz and is headquartered in Beverly Hills, CA. | Health Technology |
